Mantis Biotech's Digital Twins Fill Medicine's Data Void—Starting with NBA Stars
Imagine predicting an NFL star's Achilles snap before it happens. Mantis Biotech's digital twins could make that real, but medicine's real test lies ahead.
⚡ Key Takeaways
- Mantis uses LLMs and physics to create realistic digital twins, solving data scarcity in rare diseases and sports.
- Early NBA success proves concept; med applications face FDA hurdles but hold massive potential.
- Strategy smart: low-reg sports funds high-stakes biomed pivot, eyeing $48B market.
🧠 What's your take on this?
Cast your vote and see what theAIcatchup readers think
Worth sharing?
Get the best AI stories of the week in your inbox — no noise, no spam.
Originally reported by TechCrunch - AI